SYRS - Syros Pharmaceuticals EPS beats by $0.02 beats on revenue August, 06 2020 07:41 AM Syros Pharmaceuticals Inc. Syros Pharmaceuticals (NASDAQ:SYRS): Q2 GAAP EPS of -$0.38 beats by $0.02.More news on: Syros Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...